FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022

Dec 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-12-28

Reporting Person: Raykov Rosty (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-28	Common shares	S	13740	$9.59	Disposed	232838	Direct
2022-12-29	Common shares	S	5000	$9.65	Disposed	227838	Direct
2022-12-30	Common shares	S	1600	$9.6586	Disposed	226238	Direct
2022-12-30	Common shares	S	8400	$9.6135	Disposed	217838	Direct

Footnotes

F1: Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022.

F2: Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022.

F3: Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022.

F4: Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022.